chills with semaglutide Wegovy (Semaglutide): Uses, Side Effects, Dosage & More GLP-1 Feeling Cold

For people with diabetes taking insulin or sulfonylureas, there is an increased risk of hypoglycaemia when adding Wegovy, and dose adjustments of these medications may be needed

Currently, yes semaglutide has proven cardiovascular benefit from the SELECT trial (2023), which demonstrated significant reduction in major adverse cardiovascular events (heart attack, stroke, cardiovascular death) in patients with obesity and established heart disease

Failure to include these warnings on the drug label leaves Novo Nordisk and other GLP-1 agonist manufacturers open to liability for victims damages and suffering

Scenario 1: starting your first semaglutide protocol You receive a 5 mg vial of lyophilized semaglutide